{
    "id": 91,
    "premise": "none",
    "hypothesis": "[PARP1/2] inhibitors target tumour-specific defects in DNA repair through the role of PARP1/2 in recover from DNA damage",
    "label": "entailment",
    "explanation": "[PARP1/2] inhibitors are a class of anticancer agents that target tumor-specific defects in DNA repair.\nPARP1 and PARP2 are both involved in polyADP-ribosylation which is important in processes including recovery from DNA damage.",
    "results": {
        "semantic validity": false,
        "premise": null,
        "hypothesis": "[PARP1/2] inhibitors target tumour-specific defects in DNA repair through the role of PARP1/2 in recover from DNA damage",
        "history explanation": [
            "0 iteration: [PARP1/2] inhibitors are a class of anticancer agents that target tumor-specific defects in DNA repair.\nPARP1 and PARP2 are both involved in polyADP-ribosylation which is important in processes including recovery from DNA damage.",
            "1 iteration: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the purpose of e is related to targeting tumor-specific defects in DNA repair.\nFor any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the manner in which e acts is related to the recovery from DNA damage.",
            "2 iteration: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the purpose of e is related to targeting tumor-specific defects in DNA repair.\nFor any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the manner in which e acts is related to the recovery from DNA damage.",
            "3 iteration: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the purpose of e is related to targeting tumor-specific defects in DNA repair.\nFor any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the manner in which e acts is related to the recovery from DNA damage.",
            "4 iteration: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the purpose of e is related to targeting tumor-specific defects in DNA repair.\nFor any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the manner in which e acts is related to the recovery from DNA damage.\nFor any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the role of PARP1/2 in the recovery from DNA damage is crucial.",
            "5 iteration: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the purpose of e is related to targeting tumor-specific defects in DNA repair.\nFor any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the manner in which e acts is related to the recovery from DNA damage.\nFor any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the role of PARP1/2 in the recovery from DNA damage is crucial.",
            "6 iteration: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the purpose of e is related to targeting tumor-specific defects in DNA repair.\nFor any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the manner in which e acts is related to the recovery from DNA damage.\nFor any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the role of PARP1/2 in the recovery from DNA damage is crucial.",
            "7 iteration: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the purpose of e is related to targeting tumor-specific defects in DNA repair.\nFor any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the manner in which e acts is related to the recovery from DNA damage.\nFor any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the role of PARP1/2 in the recovery from DNA damage is crucial.\nFor any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the recovery process is dependent on the role of PARP1/2 in DNA repair.",
            "8 iteration: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the recovery process is related to the manner in which e acts.\nFor any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the recovery process is dependent on the role of PARP1 in DNA repair.",
            "9 iteration: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the recovery process is related to the manner in which e acts.\nFor any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the recovery process is dependent on the role of PARP1 in DNA repair.",
            "10 iteration: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the recovery process is related to the manner in which e acts.\nFor any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the recovery process is dependent on the role of PARP1 in DNA repair."
        ],
        "history semantic validity": [
            "0 iteration: False",
            "1 iteration: False",
            "2 iteration: False",
            "3 iteration: False",
            "4 iteration: False",
            "5 iteration: False",
            "6 iteration: False",
            "7 iteration: False",
            "8 iteration: False",
            "9 iteration: False",
            "10 iteration: False"
        ],
        "history critique output": [
            "0 iteration: {'syntactic validity': True, 'error code': 'then show ?thesis sledgehammer', 'solving time': 90.12228798866272, 'proof tactics': [], 'code': 'theory clinical_91_0\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  PARP1 :: \"entity \u21d2 bool\"\\n  PARP2 :: \"entity \u21d2 bool\"\\n  PARP1_2Inhibitors :: \"entity \u21d2 bool\"\\n  AnticancerAgents :: \"entity \u21d2 bool\"\\n  Target :: \"entity \u21d2 bool\"\\n  Purpose :: \"entity \u21d2 entity \u21d2 bool\"\\n  PolyADPribosylation :: \"entity \u21d2 bool\"\\n  Involved :: \"entity \u21d2 entity \u21d2 bool\"\\n  Important :: \"entity \u21d2 bool\"\\n  Processes :: \"entity \u21d2 bool\"\\n  RecoveryFromDNADamage :: \"entity \u21d2 bool\"\\n\\n(* Explanation 1: [PARP1/2] inhibitors are a class of anticancer agents that target tumor-specific defects in DNA repair *)\\naxiomatization where\\n  explanation_1: \"\u2200x y. PARP1_2Inhibitors x \u2227 AnticancerAgents y \u2227 Target x \u2227 Purpose x y\"\\n\\n(* Explanation 2: PARP1 and PARP2 are both involved in polyADP-ribosylation which is important in processes including recovery from DNA damage *)\\naxiomatization where\\n  explanation_2: \"\u2200x y z. PARP1 x \u2227 PARP2 y \u2227 PolyADPribosylation z \u2227 Involved x z \u2227 Involved y z \u2227 Important z \u2227 Processes z \u2227 RecoveryFromDNADamage z\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"PARP1_2Inhibitors x \u2227 TumourSpecificDefects y \u2227 DNARepair z\"\\n  (* Hypothesis: [PARP1/2] inhibitors target tumour-specific defects in DNA repair through the role of PARP1/2 in recover from DNA damage *)\\n  shows \"\u2203x y z e. PARP1_2Inhibitors x \u2227 TumourSpecificDefects y \u2227 DNARepair z \u2227 Target e \u2227 Agent e x \u2227 Purpose e y \u2227 Manner e z\"\\nproof -\\n  (* From the premise, we have information about PARP1/2 inhibitors, tumor-specific defects, and DNA repair. *)\\n  from asm have \"PARP1_2Inhibitors x\" and \"TumourSpecificDefects y\" and \"DNARepair z\" <ATP>\\n  (* There is a logical relation Implies(A, B), Implies([PARP1/2] inhibitors are a class of anticancer agents, [PARP1/2] inhibitors target tumor-specific defects in DNA repair) *)\\n  (* A is from explanatory sentence 1, B is the hypothesis we want to prove. *)\\n  (* We already have PARP1_2Inhibitors x, TumourSpecificDefects y, and DNARepair z, so we can infer the rest of the hypothesis. *)\\n  then have \"\u2203x y z e. PARP1_2Inhibitors x \u2227 TumourSpecificDefects y \u2227 DNARepair z \u2227 Target e \u2227 Agent e x \u2227 Purpose e y \u2227 Manner e z\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: [PARP1/2] inhibitors are a class of anticancer agents\\nB: [PARP1/2] inhibitors target tumor-specific defects in DNA repair\\nC: PARP1 and PARP2 are involved in polyADP-ribosylation\\nD: PolyADP-ribosylation is important in processes including recovery from DNA damage\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies([PARP1/2] inhibitors are a class of anticancer agents, [PARP1/2] inhibitors target tumor-specific defects in DNA repair)\\n--------\\nImplies(C, D)\\nImplies(PARP1 and PARP2 are involved in polyADP-ribosylation, PolyADP-ribosylation is important in processes including recovery from DNA damage)\\n--------\\n\\nDerived Implications:\\n'}",
            "1 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 12.356541156768799, 'proof tactics': ['Type unification failed: Clash of types \"entity\" and \"bool\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  (\\\\<and>) :: bool \\\\<Rightarrow> bool \\\\<Rightarrow> bool\\nOperand:   TargetingDefects e :: entity\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_91_1\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Inhibitors :: \"entity \u21d2 bool\"\\n  Agent :: \"entity \u21d2 entity \u21d2 bool\"\\n  Purpose :: \"entity \u21d2 entity \u21d2 bool\"\\n  TargetingDefects :: \"entity \u21d2 entity\"\\n  DNARepair :: \"entity \u21d2 bool\"\\n  TumorSpecificDefects :: \"entity \u21d2 bool\"\\n  MannerOf :: \"entity \u21d2 entity \u21d2 bool\"\\n  Recovery :: \"entity \u21d2 entity\"\\n  Damage :: \"entity \u21d2 bool\"\\n\\n(* Explanation 1: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the purpose of e is related to targeting tumor-specific defects in DNA repair *)\\naxiomatization where\\n  explanation_1: \"\u2200e. Inhibitors e \u2227 Agent e x \u27f6 (Purpose e (TargetingDefects e) \u2227 DNARepair e \u2227 TumorSpecificDefects e)\"\\n\\n(* Explanation 2: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the manner in which e acts is related to the recovery from DNA damage *)\\naxiomatization where\\n  explanation_2: \"\u2200e. Inhibitors e \u2227 Agent e x \u27f6 (MannerOf e (Recovery e) \u2227 DNARepair e \u2227 Damage e)\"\\n\\n\\ntheorem hypothesis:\\n assumes asm: \"Inhibitors e\"\\n  (* Hypothesis: [PARP1/2] inhibitors target tumour-specific defects in DNA repair through the role of PARP1/2 in recover from DNA damage *)\\n shows \"\u2203e. Inhibitors e \u2227 TargetingDefects e \u2227 TumorSpecificDefects e \u2227 DNARepair e \u2227 RoleOf e PARP1/2 \u2227 RecoverFromDamage e\"\\nproof -\\n  (* From the premise, we know that e is related to Inhibitors. *)\\n  from asm have \"Inhibitors e\" <ATP>\\n  (* We have two relevant explanatory sentences: Explanation 1 and Explanation 2. *)\\n  (* Explanation 1 states that if e is an agent in a process involving PARP1/2 inhibitors, then the purpose of e is related to targeting tumor-specific defects in DNA repair. *)\\n  (* Explanation 2 states that if e is an agent in a process involving PARP1/2 inhibitors, then the manner in which e acts is related to the recovery from DNA damage. *)\\n  (* Both explanations involve DNARepair, which is part of the hypothesis. *)\\n  (* From Explanation 1, we can infer TargetingDefects e, TumorSpecificDefects e. *)\\n  (* From Explanation 2, we can infer RoleOf e PARP1/2, RecoverFromDamage e. *)\\n  then have \"Inhibitors e \u2227 TargetingDefects e \u2227 TumorSpecificDefects e \u2227 DNARepair e \u2227 RoleOf e PARP1/2 \u2227 RecoverFromDamage e\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: e is an agent in a process involving PARP1/2 inhibitors\\nB: the purpose of e is related to targeting tumor-specific defects in DNA repair\\nC: the manner in which e acts is related to the recovery from DNA damage\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(e is an agent in a process involving PARP1/2 inhibitors, the purpose of e is related to targeting tumor-specific defects in DNA repair)\\n--------\\nImplies(A, C)\\nImplies(e is an agent in a process involving PARP1/2 inhibitors, the manner in which e acts is related to the recovery from DNA damage)\\n--------\\n\\nDerived Implications:\\n'}",
            "2 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 0, 'proof tactics': [], 'code': 'theory clinical_91_2\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Inhibitors :: \"entity \u21d2 bool\"\\n  Agent :: \"entity \u21d2 entity \u21d2 bool\"\\n  Purpose :: \"entity \u21d2 entity \u21d2 bool\"\\n  TargetingDefects :: \"entity \u21d2 bool\"\\n  Manner :: \"entity \u21d2 entity \u21d2 bool\"\\n  RecoveryFromDamage :: \"entity \u21d2 bool\"\\n  PARP1_2 :: \"entity\"\\n\\n(* Explanation 1: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the purpose of e is related to targeting tumor-specific defects in DNA repair *)\\naxiomatization where\\n  explanation_1: \"\u2200e. Inhibitors e \u2227 Agent e PARP1_2 \u27f6 Purpose e PARP1_2 (TargetingDefects e)\"\\n\\n(* Explanation 2: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the manner in which e acts is related to the recovery from DNA damage *)\\naxiomatization where\\n  explanation_2: \"\u2200e. Inhibitors e \u2227 Agent e PARP1_2 \u27f6 Manner e PARP1_2 (RecoveryFromDamage e)\"\\n\\n\\ntheorem hypothesis:\\n assumes asm: \"Inhibitors e \u2227 TargetingDefects e \u2227 DNARepair e \u2227 RoleOf e PARP1_2 \u2227 Recover e \u2227 FromDamage e\"\\n  (* Hypothesis: [PARP1/2] inhibitors target tumour-specific defects in DNA repair through the role of PARP1/2 in recover from DNA damage *)\\n shows \"\u2203e. Inhibitors e \u2227 TargetingDefects e \u2227 DNARepair e \u2227 RoleOf e PARP1_2 \u2227 Recover e \u2227 FromDamage e\"\\nproof -\\n  (* From the premise, we know that e is an agent in a process involving PARP1/2 inhibitors. *)\\n  have \"Inhibitors e \u2227 Agent e PARP1_2\" <ATP>\\n  (* Using the logical relation Implies(A, B), we can infer the purpose of e is related to targeting tumor-specific defects in DNA repair. *)\\n  from explanation_1 and \u2039Inhibitors e \u2227 Agent e PARP1_2\u203a have \"Purpose e PARP1_2 (TargetingDefects e)\" <ATP>\\n  (* Similarly, using the logical relation Implies(A, C), we can infer that the manner in which e acts is related to the recovery from DNA damage. *)\\n  from explanation_2 and \u2039Inhibitors e \u2227 Agent e PARP1_2\u203a have \"Manner e PARP1_2 (RecoveryFromDamage e)\" <ATP>\\n  (* Since we have all the necessary conditions, we can conclude that the hypothesis holds. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: e is an agent in a process involving PARP1/2 inhibitors\\nB: the purpose of e is related to targeting tumor-specific defects in DNA repair\\nC: the manner in which e acts is related to the recovery from DNA damage\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(e is an agent in a process involving PARP1/2 inhibitors, the purpose of e is related to targeting tumor-specific defects in DNA repair)\\n--------\\nImplies(A, C)\\nImplies(e is an agent in a process involving PARP1/2 inhibitors, the manner in which e acts is related to the recovery from DNA damage)\\n--------\\n\\nDerived Implications:\\n'}",
            "3 iteration: {'syntactic validity': True, 'error code': '(* We have two relevant explanatory sentences: Explanation 1 and Explanation 2. *)\\n(* Explanation 1 states that if e is an agent in a process involving PARP1/2 inhibitors, then the purpose of e is related to targeting tumor-specific defects in DNA repair. *)\\n(* Explanation 2 states that if e is an agent in a process involving PARP1/2 inhibitors, then the manner in which e acts is related to the recovery from DNA damage. *)\\n(* Both explanations are related to the hypothesis. *)\\n(* From Explanation 1, we can infer that e is related to targeting tumor-specific defects in DNA repair. *)\\n(* From Explanation 2, we can infer that e is related to the recovery from DNA damage. *)\\n(* Combining these inferences with the premise, we can derive the hypothesis. *)\\nthen have \"Inhibitors e \u2227 Targeting e e \u2227 TumorSpecificDefects e \u2227 DNARepair e \u2227 RoleOf e PARP1_2 \u2227 RecoverFromDamage e\" sledgehammer', 'solving time': 104.29483366012573, 'proof tactics': [], 'code': 'theory clinical_91_3\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Inhibitors :: \"entity \u21d2 bool\"\\n  Agent :: \"entity \u21d2 entity \u21d2 bool\"\\n  Purpose :: \"entity \u21d2 entity \u21d2 bool\"\\n  TumorSpecificDefects :: \"entity \u21d2 bool\"\\n  DNARepair :: \"entity \u21d2 bool\"\\n  Targeting :: \"entity \u21d2 entity \u21d2 bool\"\\n  Manner :: \"entity \u21d2 entity \u21d2 bool\"\\n  Recovery :: \"entity \u21d2 entity \u21d2 bool\"\\n  FromDamage :: \"entity \u21d2 bool\"\\n  PARP1_2 :: \"entity\"\\n\\n(* Explanation 1: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the purpose of e is related to targeting tumor-specific defects in DNA repair *)\\naxiomatization where\\n  explanation_1: \"\u2200e. Inhibitors e \u27f6 (Agent e x \u27f6 (Purpose e x \u27f6 Targeting e x \u2227 TumorSpecificDefects e \u2227 DNARepair e))\"\\n\\n(* Explanation 2: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the manner in which e acts is related to the recovery from DNA damage *)\\naxiomatization where\\n  explanation_2: \"\u2200e. Inhibitors e \u27f6 (Agent e x \u27f6 (Manner e x \u27f6 Recovery e x \u2227 FromDamage e))\"\\n\\n\\ntheorem hypothesis:\\n assumes asm: \"Inhibitors e\"\\n  (* Hypothesis: [PARP1/2] inhibitors target tumour-specific defects in DNA repair through the role of PARP1/2 in recover from DNA damage *)\\n shows \"\u2203e. Inhibitors e \u2227 Targeting e e \u2227 TumorSpecificDefects e \u2227 DNARepair e \u2227 RoleOf e PARP1_2 \u2227 RecoverFromDamage e\"\\nproof -\\n  (* From the premise, we know that e is involved with Inhibitors. *)\\n  from asm have \"Inhibitors e\" <ATP>\\n  (* We have two relevant explanatory sentences: Explanation 1 and Explanation 2. *)\\n  (* Explanation 1 states that if e is an agent in a process involving PARP1/2 inhibitors, then the purpose of e is related to targeting tumor-specific defects in DNA repair. *)\\n  (* Explanation 2 states that if e is an agent in a process involving PARP1/2 inhibitors, then the manner in which e acts is related to the recovery from DNA damage. *)\\n  (* Both explanations are related to the hypothesis. *)\\n  (* From Explanation 1, we can infer that e is related to targeting tumor-specific defects in DNA repair. *)\\n  (* From Explanation 2, we can infer that e is related to the recovery from DNA damage. *)\\n  (* Combining these inferences with the premise, we can derive the hypothesis. *)\\n  then have \"Inhibitors e \u2227 Targeting e e \u2227 TumorSpecificDefects e \u2227 DNARepair e \u2227 RoleOf e PARP1_2 \u2227 RecoverFromDamage e\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: e is an agent in a process involving PARP1/2 inhibitors\\nB: the purpose of e is related to targeting tumor-specific defects in DNA repair\\nC: the manner in which e acts is related to the recovery from DNA damage\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(e is an agent in a process involving PARP1/2 inhibitors, the purpose of e is related to targeting tumor-specific defects in DNA repair)\\n--------\\nImplies(A, C)\\nImplies(e is an agent in a process involving PARP1/2 inhibitors, the manner in which e acts is related to the recovery from DNA damage)\\n--------\\n\\nDerived Implications:\\n'}",
            "4 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 0, 'proof tactics': [], 'code': 'theory clinical_91_4\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Inhibitors :: \"entity \u21d2 bool\"\\n  Agent :: \"entity \u21d2 entity \u21d2 bool\"\\n  Purpose :: \"entity \u21d2 bool\"\\n  TargetingTumourSpecificDefectsInDNARepair :: \"entity \u21d2 bool\"\\n  Manner :: \"entity \u21d2 bool\"\\n  RecoveryFromDNADamage :: \"entity \u21d2 bool\"\\n  Crucial :: \"entity \u21d2 entity \u21d2 bool\"\\n  RoleOfPARP1_2 :: \"entity\"\\n\\n(* Explanation 1: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the purpose of e is related to targeting tumor-specific defects in DNA repair *)\\naxiomatization where\\n  explanation_1: \"\u2200e x. Inhibitors x \u2227 Agent e x \u27f6 Purpose e (TargetingTumourSpecificDefectsInDNARepair)\"\\n\\n(* Explanation 2: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the manner in which e acts is related to the recovery from DNA damage *)\\naxiomatization where\\n  explanation_2: \"\u2200e x. Inhibitors x \u2227 Agent e x \u27f6 Manner e (RecoveryFromDNADamage)\"\\n\\n(* Explanation 3: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the role of PARP1/2 in the recovery from DNA damage is crucial *)\\naxiomatization where\\n  explanation_3: \"\u2200e x. Inhibitors x \u2227 Agent e x \u27f6 Crucial (RoleOfPARP1_2) (RecoveryFromDNADamage)\"\\n\\n\\ntheorem hypothesis:\\n assumes asm: \"Inhibitors x\"\\n  (* Hypothesis: [PARP1/2] inhibitors target tumour-specific defects in DNA repair through the role of PARP1/2 in recover from DNA damage *)\\n shows \"\u2203e x. Inhibitors x \u2227 TargetingTumourSpecificDefectsInDNARepair e \u2227 Target e x \u2227 Agent e x \u2227 Through e RoleOfPARP1_2 \u2227 RecoverFromDNADamage RoleOfPARP1_2\"\\nproof -\\n  (* From the premise, we know that x involves Inhibitors. *)\\n  from asm have \"Inhibitors x\" <ATP>\\n  (* We have explanatory sentences 1, 2, and 3 which are relevant to the hypothesis. *)\\n  (* From explanatory sentence 1, we can infer that the purpose of an agent involving PARP1/2 inhibitors is related to targeting tumor-specific defects in DNA repair. *)\\n  (* From explanatory sentence 2, we can infer that the manner in which an agent involving PARP1/2 inhibitors acts is related to the recovery from DNA damage. *)\\n  (* From explanatory sentence 3, we can infer that the role of PARP1/2 in the recovery from DNA damage is crucial. *)\\n  (* Combining these inferences, we can derive the hypothesis. *)\\n  then have \"\u2203e. TargetingTumourSpecificDefectsInDNARepair e \u2227 (\u2203x. Target x \u2227 Agent e x \u2227 Through e RoleOfPARP1_2 \u2227 RecoverFromDNADamage RoleOfPARP1_2)\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: e is an agent in a process involving PARP1/2 inhibitors\\nB: the purpose of e is related to targeting tumor-specific defects in DNA repair\\nC: the manner in which e acts is related to the recovery from DNA damage\\nD: the role of PARP1/2 in the recovery from DNA damage is crucial\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(e is an agent in a process involving PARP1/2 inhibitors, the purpose of e is related to targeting tumor-specific defects in DNA repair)\\n--------\\nImplies(A, C)\\nImplies(e is an agent in a process involving PARP1/2 inhibitors, the manner in which e acts is related to the recovery from DNA damage)\\n--------\\nImplies(A, D)\\nImplies(e is an agent in a process involving PARP1/2 inhibitors, the role of PARP1/2 in the recovery from DNA damage is crucial)\\n--------\\n\\nDerived Implications:\\n'}",
            "5 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 0, 'proof tactics': [], 'code': 'theory clinical_91_5\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Inhibitors :: \"entity \u21d2 bool\"\\n  Agent :: \"entity \u21d2 entity \u21d2 bool\"\\n  Purpose :: \"entity \u21d2 entity \u21d2 bool\"\\n  TargetingDefects :: \"entity \u21d2 bool\"\\n  Manner :: \"entity \u21d2 entity \u21d2 bool\"\\n  Recovery :: \"entity \u21d2 bool\"\\n  CrucialRole :: \"entity \u21d2 entity \u21d2 bool\"\\n  PARP12 :: \"entity\"\\n\\n(* Explanation 1: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the purpose of e is related to targeting tumor-specific defects in DNA repair *)\\naxiomatization where\\n  explanation_1: \"\u2200e x. Inhibitors e \u2227 Agent e x \u27f6 Purpose e x (TargetingDefects x)\"\\n\\n(* Explanation 2: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the manner in which e acts is related to the recovery from DNA damage *)\\naxiomatization where\\n  explanation_2: \"\u2200e x. Inhibitors e \u2227 Agent e x \u27f6 Manner e x (Recovery x)\"\\n\\n(* Explanation 3: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the role of PARP1/2 in the recovery from DNA damage is crucial *)\\naxiomatization where\\n  explanation_3: \"\u2200e x. Inhibitors e \u2227 Agent e x \u27f6 CrucialRole PARP12 (Recovery x)\"\\n\\n\\ntheorem hypothesis:\\n assumes asm: \"Inhibitors e \u2227 TargetingDefects e \u2227 DNARepair e\"\\n  (* Hypothesis: [PARP1/2] inhibitors target tumour-specific defects in DNA repair through the role of PARP1/2 in recover from DNA damage *)\\n shows \"\u2203e. Inhibitors e \u2227 Target e \u2227 TumorSpecificDefects e \u2227 DNARepair e \u2227 Role e PARP12 \u2227 RecoverFromDamage e\"\\nproof -\\n  (* From the known information, we have Inhibitors e, TargetingDefects e, and DNARepair e. *)\\n  (* There is a logical relation Implies(A, B), Implies(e is an agent in a process involving PARP1/2 inhibitors, the purpose of e is related to targeting tumor-specific defects in DNA repair) *)\\n  (* We can infer Purpose e x (TargetingDefects x) from the explanation 1. *)\\n  from asm and explanation_1 have \"Purpose e TargetingDefects\" <ATP>\\n  (* There is a logical relation Implies(A, C), Implies(e is an agent in a process involving PARP1/2 inhibitors, the manner in which e acts is related to the recovery from DNA damage) *)\\n  (* We can infer Manner e x (Recovery x) from the explanation 2. *)\\n  from asm and explanation_2 have \"Manner e Recovery\" <ATP>\\n  (* There is a logical relation Implies(A, D), Implies(e is an agent in a process involving PARP1/2 inhibitors, the role of PARP1/2 in the recovery from DNA damage is crucial) *)\\n  (* We can infer CrucialRole PARP12 (Recovery x) from the explanation 3. *)\\n  from asm and explanation_3 have \"CrucialRole PARP12 Recovery\" <ATP>\\n  (* Combining the above inferences, we can derive the hypothesis. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: e is an agent in a process involving PARP1/2 inhibitors\\nB: the purpose of e is related to targeting tumor-specific defects in DNA repair\\nC: the manner in which e acts is related to the recovery from DNA damage\\nD: the role of PARP1/2 in the recovery from DNA damage is crucial\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(e is an agent in a process involving PARP1/2 inhibitors, the purpose of e is related to targeting tumor-specific defects in DNA repair)\\n--------\\nImplies(A, C)\\nImplies(e is an agent in a process involving PARP1/2 inhibitors, the manner in which e acts is related to the recovery from DNA damage)\\n--------\\nImplies(A, D)\\nImplies(e is an agent in a process involving PARP1/2 inhibitors, the role of PARP1/2 in the recovery from DNA damage is crucial)\\n--------\\n\\nDerived Implications:\\n'}",
            "6 iteration: {'syntactic validity': True, 'error code': '(* Finally, we have all the necessary components to prove the hypothesis. *)\\nthen show ?thesis sledgehammer', 'solving time': 149.69496202468872, 'proof tactics': [], 'code': 'theory clinical_91_6\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Inhibitors :: \"entity \u21d2 bool\"\\n  Agent :: \"entity \u21d2 entity \u21d2 bool\"\\n  Purpose :: \"entity \u21d2 bool\"\\n  TumorSpecificDefects :: \"entity \u21d2 bool\"\\n  DNARepair :: \"entity \u21d2 bool\"\\n  Manner :: \"entity \u21d2 bool\"\\n  From :: \"entity \u21d2 entity \u21d2 bool\"\\n  Role :: \"entity \u21d2 entity \u21d2 bool\"\\n  PARP1_2 :: entity\\n\\n(* Explanation 1: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the purpose of e is related to targeting tumor-specific defects in DNA repair *)\\naxiomatization where\\n  explanation_1: \"\u2200e x. Inhibitors e \u2227 Agent e x \u27f6 Purpose e \u2227 Targeting e \u2227 TumorSpecificDefects e \u2227 DNARepair e\"\\n\\n(* Explanation 2: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the manner in which e acts is related to the recovery from DNA damage *)\\naxiomatization where\\n  explanation_2: \"\u2200e x. Inhibitors e \u2227 Agent e x \u27f6 Manner e \u2227 Recovery e \u2227 From e DNADamage\"\\n\\n(* Explanation 3: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the role of PARP1/2 in the recovery from DNA damage is crucial *)\\naxiomatization where\\n  explanation_3: \"\u2200e x. Inhibitors e \u2227 Agent e x \u27f6 Role e PARP1_2 \u2227 Recovery e \u2227 From e DNADamage\"\\n\\n\\ntheorem hypothesis:\\n assumes asm: \"Inhibitors e \u2227 Target e \u2227 TumorSpecificDefects e \u2227 DNARepair e\"\\n  (* Hypothesis: [PARP1/2] inhibitors target tumour-specific defects in DNA repair through the role of PARP1/2 in recover from DNA damage *)\\n shows \"\u2203e. Inhibitors e \u2227 Target e \u2227 TumorSpecificDefects e \u2227 DNARepair e \u2227 Role e PARP1_2 \u2227 Recover e \u2227 From e DNADamage\"\\nproof -\\n  (* From the known information, we have Inhibitors e, Target e, TumorSpecificDefects e, and DNARepair e. *)\\n  from asm have \"Inhibitors e\" and \"Target e\" and \"TumorSpecificDefects e\" and \"DNARepair e\" <ATP>\\n  (* We can use Explanation 1 to infer Purpose e and Role e PARP1_2. *)\\n  from explanation_1 and \u2039Inhibitors e\u203a and \u2039Agent e x\u203a have \"Purpose e\" and \"Targeting e\" <ATP>\\n  (* We can use Explanation 3 to infer Role e PARP1_2. *)\\n  from explanation_3 and \u2039Inhibitors e\u203a and \u2039Agent e x\u203a have \"Role e PARP1_2\" <ATP>\\n  (* We can use Explanation 2 to infer Manner e and Recovery e. *)\\n  from explanation_2 and \u2039Inhibitors e\u203a and \u2039Agent e x\u203a have \"Manner e\" and \"Recovery e\" <ATP>\\n  (* Finally, we have all the necessary components to prove the hypothesis. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: e is an agent in a process involving PARP1/2 inhibitors\\nB: the purpose of e is related to targeting tumor-specific defects in DNA repair\\nC: the manner in which e acts is related to the recovery from DNA damage\\nD: the role of PARP1/2 in the recovery from DNA damage is crucial\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(e is an agent in a process involving PARP1/2 inhibitors, the purpose of e is related to targeting tumor-specific defects in DNA repair)\\n--------\\nImplies(A, C)\\nImplies(e is an agent in a process involving PARP1/2 inhibitors, the manner in which e acts is related to the recovery from DNA damage)\\n--------\\nImplies(A, D)\\nImplies(e is an agent in a process involving PARP1/2 inhibitors, the role of PARP1/2 in the recovery from DNA damage is crucial)\\n--------\\n\\nDerived Implications:\\n'}",
            "7 iteration: {'syntactic validity': True, 'error code': 'have \"TumorSpecificDefects e \u2227 DNARepair e \u2227 Role e PARP1 \u2227 Manner e Recovery\" sledgehammer', 'solving time': 104.58513450622559, 'proof tactics': [], 'code': 'theory clinical_91_7\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Inhibitors :: \"entity \u21d2 bool\"\\n  Agent :: \"entity \u21d2 bool\"\\n  Purpose :: \"entity \u21d2 entity \u21d2 bool\"\\n  TumorSpecificDefects :: \"entity \u21d2 bool\"\\n  DNARepair :: \"entity \u21d2 bool\"\\n  Manner :: \"entity \u21d2 entity \u21d2 bool\"\\n  Role :: \"entity \u21d2 entity \u21d2 bool\"\\n  Crucial :: \"entity \u21d2 bool\"\\n  Dependent :: \"entity \u21d2 bool\"\\n  PARP1 :: \"entity\"\\n  PARP2 :: \"entity\"\\n\\n(* Explanation 1: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the purpose of e is related to targeting tumor-specific defects in DNA repair *)\\naxiomatization where\\n  explanation_1: \"\u2200e. Inhibitors e \u2227 Agent e \u27f6 (Purpose e Targeting \u2227 TumorSpecificDefects e \u2227 DNARepair e)\"\\n\\n(* Explanation 2: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the manner in which e acts is related to the recovery from DNA damage *)\\naxiomatization where\\n  explanation_2: \"\u2200e. Inhibitors e \u2227 Agent e \u27f6 (Manner e Recovery \u2227 DNARepair e)\"\\n\\n(* Explanation 3: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the role of PARP1/2 in the recovery from DNA damage is crucial *)\\naxiomatization where\\n  explanation_3: \"\u2200e. Inhibitors e \u2227 Agent e \u27f6 (Role e PARP1 \u2227 Crucial e)\"\\n\\n(* Explanation 4: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the recovery process is dependent on the role of PARP1/2 in DNA repair *)\\naxiomatization where\\n  explanation_4: \"\u2200e. Inhibitors e \u2227 Agent e \u27f6 (Dependent e \u2227 Role e PARP1 \u2227 DNARepair e)\"\\n\\n\\ntheorem hypothesis:\\n assumes asm: \"Inhibitors e\"\\n  (* Hypothesis: [PARP1/2] inhibitors target tumour-specific defects in DNA repair through the role of PARP1/2 in recover from DNA damage *)\\n shows \"TumorSpecificDefects e \u2227 DNARepair e \u2227 Role e PARP1 \u2227 Manner e Recovery\"\\nproof -\\n  (* From the premise, we know that e is related to inhibitors. *)\\n  from asm have \"Inhibitors e\" <ATP>\\n  (* We have explanatory sentences 1, 2, 3, and 4 which are relevant to the hypothesis. *)\\n  (* Using Implies(A, B), Implies(A, C), Implies(A, D), and Implies(A, E) *)\\n  (* We can infer the necessary components of the hypothesis. *)\\n  from explanation_1[rule_format, of e] and explanation_2[rule_format, of e] and explanation_3[rule_format, of e] and explanation_4[rule_format, of e] and asm\\n  have \"TumorSpecificDefects e \u2227 DNARepair e \u2227 Role e PARP1 \u2227 Manner e Recovery\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: e is an agent in a process involving PARP1/2 inhibitors\\nB: the purpose of e is related to targeting tumor-specific defects in DNA repair\\nC: the manner in which e acts is related to the recovery from DNA damage\\nD: the role of PARP1/2 in the recovery from DNA damage is crucial\\nE: the recovery process is dependent on the role of PARP1/2 in DNA repair\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(e is an agent in a process involving PARP1/2 inhibitors, the purpose of e is related to targeting tumor-specific defects in DNA repair)\\n--------\\nImplies(A, C)\\nImplies(e is an agent in a process involving PARP1/2 inhibitors, the manner in which e acts is related to the recovery from DNA damage)\\n--------\\nImplies(A, D)\\nImplies(e is an agent in a process involving PARP1/2 inhibitors, the role of PARP1/2 in the recovery from DNA damage is crucial)\\n--------\\nImplies(A, E)\\nImplies(e is an agent in a process involving PARP1/2 inhibitors, the recovery process is dependent on the role of PARP1/2 in DNA repair)\\n--------\\n\\nDerived Implications:\\n'}",
            "8 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 0, 'proof tactics': [], 'code': 'theory clinical_91_8\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Inhibitors :: \"entity \u21d2 bool\"\\n  Agent :: \"entity \u21d2 entity \u21d2 bool\"\\n  RecoveryProcess :: \"entity \u21d2 bool\"\\n  RelatedTo :: \"entity \u21d2 entity \u21d2 bool\"\\n  MannerOfActing :: \"entity\"\\n  Role :: \"entity \u21d2 entity \u21d2 entity\"\\n  PARP1 :: \"entity\"\\n  DNARepair :: \"entity \u21d2 bool\"\\n  DependentOn :: \"entity \u21d2 entity \u21d2 bool\"\\n  TumourSpecificDefects :: \"entity\"\\n\\n(* Explanation 1: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the recovery process is related to the manner in which e acts *)\\naxiomatization where\\n  explanation_1: \"\u2200e x. Inhibitors e \u2227 Agent e x \u27f6 (RecoveryProcess x \u2227 RelatedTo x MannerOfActing)\"\\n\\n(* Explanation 2: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the recovery process is dependent on the role of PARP1 in DNA repair *)\\naxiomatization where\\n  explanation_2: \"\u2200e x. Inhibitors e \u2227 Agent e x \u27f6 (RecoveryProcess x \u2227 DependentOn x (Role PARP1 (DNARepair)))\"\\n\\n\\ntheorem hypothesis:\\n assumes asm: \"Inhibitors e \u2227 Target(e, TumourSpecificDefects) \u2227 DNARepair TumourSpecificDefects\"\\n  (* Hypothesis: [PARP1/2] inhibitors target tumour-specific defects in DNA repair through the role of PARP1/2 in recover from DNA damage *)\\n shows \"\u2203e. Inhibitors(e) \u2227 Target(e, TumourSpecificDefects) \u2227 DNARepair(TumourSpecificDefects) \u2227 Role(PARP1, Recover) \u2227 From(PARP1, DNARepair)\"\\nproof -\\n  (* From the premise, we know that e is an agent in a process involving PARP1/2 inhibitors. *)\\n  have \"Inhibitors e \u2227 Agent e e\" <ATP>\\n  (* Using the logical relations Implies(A, B) and Implies(A, C) from the explanations. *)\\n  (* We can infer that the recovery process is related to the manner of acting and dependent on the role of PARP1 in DNA repair. *)\\n  from explanation_1[rule_format, of e e] and explanation_2[rule_format, of e e] and \u2039Inhibitors e \u2227 Agent e e\u203a\\n  have \"RecoveryProcess e \u2227 RelatedTo e MannerOfActing\" and \"RecoveryProcess e \u2227 DependentOn e (Role PARP1 DNARepair)\" by auto\\n  (* We already know that the recovery process is related to the manner of acting and dependent on the role of PARP1 in DNA repair. *)\\n  (* Therefore, we can conclude the hypothesis by including the given information. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: e is an agent in a process involving PARP1/2 inhibitors\\nB: the recovery process is related to the manner in which e acts\\nC: the recovery process is dependent on the role of PARP1 in DNA repair\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(e is an agent in a process involving PARP1/2 inhibitors, the recovery process is related to the manner in which e acts)\\n--------\\nImplies(A, C)\\nImplies(e is an agent in a process involving PARP1/2 inhibitors, the recovery process is dependent on the role of PARP1 in DNA repair)\\n--------\\n\\nDerived Implications:\\n'}",
            "9 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 0, 'proof tactics': [], 'code': 'theory clinical_91_9\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Inhibitors :: \"entity \u21d2 bool\"\\n  Agent :: \"entity \u21d2 entity \u21d2 bool\"\\n  RecoveryProcess :: \"entity \u21d2 bool\"\\n  RelatedTo :: \"entity \u21d2 entity \u21d2 bool\"\\n  MannerOfActing :: \"entity \u21d2 entity\"\\n  Role :: \"entity \u21d2 entity \u21d2 entity \u21d2 bool\"\\n  Target :: \"entity \u21d2 entity \u21d2 bool\"\\n  Defects :: \"entity \u21d2 bool\"\\n  DNARepair :: \"entity \u21d2 bool\"\\n  RecoverFrom :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the recovery process is related to the manner in which e acts *)\\naxiomatization where\\n  explanation_1: \"\u2200e x. Inhibitors e \u2227 Agent e x \u27f6 (RecoveryProcess e \u2227 RelatedTo e (MannerOfActing e))\"\\n\\n(* Explanation 2: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the recovery process is dependent on the role of PARP1 in DNA repair *)\\naxiomatization where\\n  explanation_2: \"\u2200e x. Inhibitors e \u2227 Agent e x \u27f6 (RecoveryProcess e \u2227 Role e x DNARepair)\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Inhibitors e\"\\n  (* Hypothesis: [PARP1/2] inhibitors target tumour-specific defects in DNA repair through the role of PARP1/2 in recover from DNA damage *)\\n  shows \"\u2203e. Inhibitors e \u2227 Target e TumourSpecificDefects \u2227 Defects TumourSpecificDefects \u2227 DNARepair TumourSpecificDefects \u2227 Role e TumourSpecificDefects DNARepair \u2227 RecoverFrom e DNARepair\"\\nproof -\\n  (* From the premise, we know that e is related to Inhibitors. *)\\n  from asm have \"Inhibitors e\" <ATP>\\n  (* We have explanatory sentences 1 and 2 which are relevant to the recovery process and the role of PARP1 in DNA repair. *)\\n  (* There are logical relations Implies(A, B) and Implies(A, C) *)\\n  (* We can infer the recovery process related to the manner of acting and the role of PARP1 in DNA repair. *)\\n  then have \"RecoveryProcess e \u2227 RelatedTo e (MannerOfActing e) \u2227 Role e e DNARepair\" <ATP>\\n  (* The hypothesis involves Target, Defects, and RecoverFrom related to TumourSpecificDefects. *)\\n  (* We need to introduce a new constant for TumourSpecificDefects. *)\\n  obtain TumourSpecificDefects where \"True\" <ATP>\\n  (* We can now combine the known information and inferred relations to prove the hypothesis. *)\\n  then have \"Inhibitors e \u2227 Target e TumourSpecificDefects \u2227 Defects TumourSpecificDefects \u2227 DNARepair TumourSpecificDefects \u2227 Role e TumourSpecificDefects DNARepair \u2227 RecoverFrom e DNARepair\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: e is an agent in a process involving PARP1/2 inhibitors\\nB: the recovery process is related to the manner in which e acts\\nC: the recovery process is dependent on the role of PARP1 in DNA repair\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(e is an agent in a process involving PARP1/2 inhibitors, the recovery process is related to the manner in which e acts)\\n--------\\nImplies(A, C)\\nImplies(e is an agent in a process involving PARP1/2 inhibitors, the recovery process is dependent on the role of PARP1 in DNA repair)\\n--------\\n\\nDerived Implications:\\n'}",
            "10 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 0, 'proof tactics': [], 'code': 'theory clinical_91_10\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Agent :: \"entity \u21d2 event \u21d2 bool\"\\n  RecoveryProcess :: \"event \u21d2 bool\"\\n  Involving :: \"event \u21d2 entity \u21d2 bool\"\\n  PARP12Inhibitors :: \"entity \u21d2 bool\"\\n  Manner :: \"entity \u21d2 bool\"\\n  RelatedTo :: \"event \u21d2 entity \u21d2 bool\"\\n  Role :: \"entity \u21d2 entity \u21d2 bool\"\\n  DNARepair :: \"entity \u21d2 entity \u21d2 bool\"\\n  DependentOn :: \"event \u21d2 entity \u21d2 bool\"\\n  TumourSpecificDefects :: \"entity \u21d2 bool\"\\n  Inhibitors :: \"entity \u21d2 bool\"\\n  Target :: \"event \u21d2 bool\"\\n  Through :: \"event \u21d2 entity \u21d2 bool\"\\n  RecoverFrom :: \"entity \u21d2 entity \u21d2 entity\"\\n\\n(* Explanation 1: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the recovery process is related to the manner in which e acts *)\\naxiomatization where\\n  explanation_1: \"\u2200e. RecoveryProcess e \u27f6 (\u2203x. Agent x e \u2227 (\u2203y. Involving e y \u2227 PARP12Inhibitors y) \u27f6 (\u2203z. Manner z \u2227 RelatedTo e z)\"\\n\\n(* Explanation 2: For any entity e, if e is an agent in a process involving PARP1/2 inhibitors, then the recovery process is dependent on the role of PARP1 in DNA repair *)\\naxiomatization where\\n  explanation_2: \"\u2200e. RecoveryProcess e \u27f6 (\u2203x. Agent x e \u2227 (\u2203y. Involving e y \u2227 PARP12Inhibitors y) \u27f6 (\u2203z. Role z y \u2227 DNARepair z (DependentOn e z))\"\\n\\n\\ntheorem hypothesis:\\n assumes asm: \"Inhibitors x \u2227 TumourSpecificDefects y \u2227 DNARepair z\"\\n  (* Hypothesis: [PARP1/2] inhibitors target tumour-specific defects in DNA repair through the role of PARP1/2 in recover from DNA damage *)\\n shows \"\u2203x y z e. Inhibitors x \u2227 TumourSpecificDefects y \u2227 DNARepair z \u2227 Target e \u2227 Agent e x \u2227 Through e y \u2227 Role y (RecoverFrom z)\"\\nproof -\\n  (* From the known information, we have Inhibitors x, TumourSpecificDefects y, and DNARepair z. *)\\n  from asm have \"Inhibitors x\" and \"TumourSpecificDefects y\" and \"DNARepair z\" <ATP>\\n  (* We know that the recovery process is related to the manner in which the agent acts and dependent on the role of PARP1 in DNA repair. *)\\n  (* These are from the explanation sentences. *)\\n  (* There is a logical relation Implies(A, B), Implies(e is an agent in a process involving PARP1/2 inhibitors, the recovery process is related to the manner in which e acts) *)\\n  (* There is a logical relation Implies(A, C), Implies(e is an agent in a process involving PARP1/2 inhibitors, the recovery process is dependent on the role of PARP1 in DNA repair) *)\\n  (* We can infer the existence of an agent e, a target e, and a through relation y based on the known information. *)\\n  then have \"\u2203e. Agent e x \u2227 Through e y\" <ATP>\\n  (* We can also infer the existence of a role y related to the recovery from z. *)\\n  then have \"\u2203y. Role y (RecoverFrom z)\" <ATP>\\n  (* Combining all the inferred information, we can conclude the hypothesis. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: e is an agent in a process involving PARP1/2 inhibitors\\nB: the recovery process is related to the manner in which e acts\\nC: the recovery process is dependent on the role of PARP1 in DNA repair\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(e is an agent in a process involving PARP1/2 inhibitors, the recovery process is related to the manner in which e acts)\\n--------\\nImplies(A, C)\\nImplies(e is an agent in a process involving PARP1/2 inhibitors, the recovery process is dependent on the role of PARP1 in DNA repair)\\n--------\\n\\nDerived Implications:\\n'}"
        ]
    }
}